Interventional oncology

Interview

Q&A With Dr. Sarah White: Expanding the Ablation Zone

08/17/2017

Ablation offers another treatment option for patients with metastatic colon cancer who are not candidates for resection, but the limited size of the ablation zone currently makes this technique effective only in patients with small...

Ablation offers another...

08/17/2017

IO Learning

News

Chemoembolization vs Radioembolization: Which Is Better for Post-Transplant Outcomes?

08/15/2017

Patients who were bridged/downstaged to orthotopic liver transplantation (OLT) by transarterial chemoembolization (TACE) or yttrium-90 (Y90) radioembolization had similar outcomes, even though Y90 patients waited longer for OLT. The...

Patients who were...

08/15/2017

IO Learning

Interview

Changes in Your Practice: How Interventional Oncology Is Evolving

08/10/2017

Interventional oncology is a rapidly evolving field, and clinicians are constantly adapting their clinical practice and office procedures to accommodate the latest advances. In this Q&A, Constantino Peña, MD, shares some of the recent changes...

Interventional oncology is a...

08/10/2017

IO Learning

Interview

Changing “Good Enough” Practice to Excellent Practice

08/03/2017

Interventional radiologists provide cutting-edge treatments to patients with cancer, but excellent patient care involves more than a successful procedure. In this Q&A, Constantino Peña, MD, offers his advice on how to bring patient care to...

Interventional radiologists...

08/03/2017

IO Learning

News

Can Cytokine Values Help in Selecting Patients for Radioembolization?

07/31/2017

Cytokine values may help to identify patients who will benefit from yttrium-90 (Y-90) radioembolization of liver malignancies. Researchers reported their findings in Cardiovascular and Interventional Radiology. The observational study...

Cytokine values may help to...

07/31/2017

IO Learning

News

Internal Radiation May Improve Outcomes in Right-sided Colorectal Tumors

07/25/2017

Combined treatment with first-line chemotherapy and selective internal radiation therapy (SIRT) led to a better survival rate in patients whose liver metastases had originated from right-sided primary colorectal tumors, compared with patients...

Combined treatment with...

07/25/2017

IO Learning

News

Is Y-90 Treatment After Major Hepatic Resection Safe and Effective?

07/25/2017

Radioembolization with yttrium-90 (Y90) in patients who have previously undergone major hepatic resection seems to be safe and effective, researchers reported. The retrospective study evaluated data from 15 patients (10 male, 5 female) with...

Radioembolization with...

07/25/2017

IO Learning

Interview

Tumor Board: From Preparation to Practice Building

07/18/2017

In this Q&A, Ripal Gandhi, MD, explains the best ways to prepare for a tumor board meeting and communicate with colleagues, particularly in areas that do not have high-quality data available. He also explains how the interventional oncologist...

In this Q&A, Ripal Gandhi, MD,...

07/18/2017

IO Learning

Interview

Four Tips for Optimizing Tumor Board Participation

07/13/2017

Tumor boards are critical to the care of patients with cancer. They enable collaboration between the various specialists involved in treatment, with interventional oncologists playing a key role. We spoke with Ripal Gandhi, MD, about how...

Tumor boards are critical to the...

07/13/2017

IO Learning

News

Certain Patients With Extrahepatic Spread May Benefit From Chemoembolization

07/12/2017

Maximum tumor size, intrahepatic tumor distribution, and the presence of portal vein tumor thrombosis (PVTT) are useful factors in predicting the likelihood of overall survival for patients with hepatocellular carcinoma (HCC) and extrahepatic...

Maximum tumor size, intrahepatic...

07/12/2017

IO Learning